Syncope and Transient Loss of Consciousness

Syncope is one of the most important causes of transient loss of consciousness, and is such a common event that it may be encountered by practitioners in virtually any field of medicine. As such, a broad spectrum of healthcare professionals may be involved in its assessment and management.

Contributors. Preface. Part 1 Syncope and TLOC overview. 1 Definition and classification of syncope and transient. loss of consciousness. Jean-Jacques Blanc. 2 Epidemiologic aspects of transient loss of consciousness/syncope. Robert S Sheldon, Anna Serletis. 3 Pathophysiology of syncope: postural, neurally-mediated,. and arrhythmic. W Wieling. 4 Cerebral perfusion in syncope. J Gert van Dijk, Roland D Thijs. 5 Risk stratification-impact on diagnostic strategy. Brian Olshansky. Part 2 Clinical evaluation strategies. 6 Value and limitations of clinical history in assessing cause of syncope. Paolo Alboni, Maurizio Dinelli. 7 Emergency department evaluation of transient loss of consciousness/. syncope. FrancCois P Sarasin. 8 The essential autonomic assessment for evaluating the. cause of syncope. Carlos A Morillo, Juan C Guzman. 9 Neurally-mediated reflex syncope: recognition by history and. clinical testing. Anna Serletis, Robert S Sheldon. 10 Value and limitations of ambulatory electrocardiographic monitoring. Andrew D Krahn. 11 Recording ambulatory blood pressure in the syncope and. TLOC evaluation. Dietrich Andresen. 12 Electrophysiologic testing: value and limitations in the transient loss of. consciousness/syncope evaluation. Suneet Mittal. 13 Intolerance to upright posture in autonomic failure and the postural. tachycardia syndrome: assessment and treatment strategies. Christopher J Mathias. 14 Improving tolerance to upright posture: current status of tilt-training. and other physical maneuvers. Hugo Ector, Tony Reybrouck. 15 Syncope in patients with bundle-branch block and other conduction. system abnormalities. Angel Moya. Part 3 Specific conditions. 16 Treatment strategies in neurally-mediated reflex syncope: effectiveness of. drugs, pacing, and physical maneuvers. Richard Sutton. 17 Structural heart disease, syncope, and risk of sudden death: selection of. patients for implantable cardioverter-defibrillator therapy. Kathy L Lee, Hung-Fat Tse, Chu-Pak Lau. 18 Channelopathies as a cause of syncope. T Boussy, Pedro Brugada. 19 Distinguishing seizures and pseudosyncope from syncope. Adam P Fitzpatrick. 20 Syncope and transient loss of consciousness in children and adolescents:. congenital and acquired conditions. Hugh Calkins. 21 Transient loss of consciousness, syncope, and falls in the elderly. Rose Anne Kenny. 22 Drug-induced (iatrogenic) syncope. Gerald V Naccarelli. Part 4 Economic and research aspects. 23 Syncope and the competitive athlete: recommendations for evaluation. and permission to compete. Franco Giada, Antonio Raviele (Ospedale Umberto I). 24 Role of syncope management units. Win K Shen, Michele Brignole (Ospedali del Tigullio). 25 The impact of syncope and transient loss of consciousness on. quality of life. Blair P Grubb. Part 5 Current controversies and future directions. 26 Driving and flying restrictions for the syncope and/or implanted. cardiac device patient. Christina M Murray, Dwight W Reynolds. 27 Clinical trials landscape: what's new, what's ongoing, what do. we need. Michele Brignole (Ospedali del Tigullio), David G Benditt (University of Minnesota Medical School), Wouter Wieling (Academic Medical Centre). 28 Syncope and transient loss of consciousness: multidisciplinary. management. A John Camm. 29 Syncope practice guidelines initiative. David G Benditt (University of Minnesota Medical School). Appendix: syncope consortium members. Index